Skip to main content

Pharmacological Properties and Mechanism of Action of Denopamine in Experimental Animals

  • Conference paper
Heart Failure Mechanisms and Management

Abstract

Denopamine is a novel phenylethanolamine derivative (Fig. 1). It is a highly selective β 1-agonist and was derived from a study on structure-activity relationships of a β 2-agonist, trimetoquinol, and was designed as an orally active positive inotropic agent with minor side effects. We report here denopamine’s pharmacological properties and mechanism of action. Denopamine has been used clinically as a remedy for chronic heart failure in Japan since 1988.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nagao T, Ikeo T, Murata S, Sato M, Nakajima H (1984) Cardiovascular effects of a new positive inotropic agent, (—)-(R)-1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart. Jpn J Pharmacol 35: 415–423

    Article  PubMed  CAS  Google Scholar 

  2. Narita H, Yabana H, Kikkawa K, Miyazaki K, Ikeo T, Nagao T (1986) Weak arrhythmogenic property of the new cardiotonic agent denopamine in dogs. Comparison with catecholamines. Jpn J Pharmacol 41: 334–344

    Article  Google Scholar 

  3. Ikeo T, Nagao T, Suzuki T, Yabana H, Nakajima H (1985) Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs. Jpn J Pharmacol 39: 191–199

    Article  PubMed  CAS  Google Scholar 

  4. Yabana H, Watanabe H, Nagao T (1989) β-Adrenoceptor selectivity and its partial agonistic action of denopamine. — Comparison with T-0509 and xamoterol —. Jpn J Pharmacol 49 [Suppl]:60P

    Google Scholar 

  5. Hosiyama M, Ikeo T, Miyazaki K, Nagao T (1985) Effects of denopamine on contractile force and heart rate, and its arrhythmogenic activity in the isolated cat heart muscle. Jpn Pharmacol Ther 13: 6323–6330

    Google Scholar 

  6. Narita H, Nagao T, Yabana H, Miyazaki K, Nosaka K, Watanabe H, Hoshiyama M (1988) Weak arrhythmogenecity and partial agonistic property of denopamine. Jpn Pharmacol Ther 16: 3089–3100

    CAS  Google Scholar 

  7. Hoshiyama M, Miyazaki K (1985) Effects of denopamine on electrical and mechanical properties of the isolated canine and guinea pig heart muscles. Jpn Pharmacol Ther 13: 6333–6342

    CAS  Google Scholar 

  8. Sato T, Imanishi S, Arita M (1985) Positive inotropic effect of denopamine (TA-064), a new cardiotonic agent, in guinea pig papillary muscle. — In comparison with isoproterenol and ouabain —. Jpn Pharmacol Ther 13: 5727–5736

    CAS  Google Scholar 

  9. Ikeo T, Nagao T (1985) Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs. Jpn J Pharmacol 39: 179–189

    Article  PubMed  CAS  Google Scholar 

  10. Yabana H, Naito K, Nagao T (1986) Effect of chronic administration of denopamine (TA-064), a new positive inotropic agent, on cardiac response of rats to denopamine. Jpn J Pharmacol 42: 87–97

    Article  PubMed  CAS  Google Scholar 

  11. Naito K, Nagao T, Ono Y, Otsuka H, Harigaya S, Nakajima H (1985) Effect ofGTP on the affinity of denopamine, a new cardiotonic agent, for β-adrenergic receptors of turkey erythrocytes and rat reticulocyte membranes. Jpn J Pharmacol 39: 541–549

    Article  PubMed  CAS  Google Scholar 

  12. Bing RJ, Sasaki Y, Burger W, Chemnitius JM (1984) Cardiac inotropic response of a new β-l-agonist (T-064) with low sarcolemmal adenylate cyclase activation. Curr Therap Res 36: 1127–1144

    CAS  Google Scholar 

  13. Sasaki Y, Yabana H, Nagao T, Takeyama S (1988) Effect of denopamine on the phosphorylation of cardiac muscle proteins in the perfused guinea-pig heart. Biochem Pharmacol 37: 679–686

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nagao, T., Sasaki, Y., Yabana, H., Hoshiyama, M., Harigaya, S. (1991). Pharmacological Properties and Mechanism of Action of Denopamine in Experimental Animals. In: Lewis, B.S., Kimchi, A. (eds) Heart Failure Mechanisms and Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58231-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58231-8_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63509-0

  • Online ISBN: 978-3-642-58231-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics